The study of neurodegenerative diseases delves into the intricate processes of neuronal decline and dysfunction, exploring the mechanisms behind disorders like amyotrophic lateral sclerosis, multiple sclerosis, and frontotemporal dementia. Cutting-edge research highlights the role of protein misfolding, mitochondrial dysfunction, and neuroinflammation in disease pathology. Therapies targeting these pathways, including small molecules, gene therapies, and stem cell-based treatments, are at the forefront of clinical trials. Efforts to integrate neuroimaging and computational models enhance the understanding of disease progression, enabling the design of precise therapeutic interventions. Collaborative advancements are reshaping the future of managing and potentially reversing the effects of these complex disorders.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Examining the effects of prenatal neurotoxin exposure on the development of the prefrontal cortex and its impact on executive functioning and attentional capacities in children
David Joseph Sperbeck, Private practice, United States
Title : Neurojourney: A free, digital, and multilingual anticipatory guidance tool for parents and clinicians caring for children with severe neurological impairment
Blyth Lord, Courageous Parents Network, United States
Title : Improving delivery of hydrophobic bioactive molecules: A water-solubility strategy with preclinical proof of concept
Loan Huynh, Trait Bioscience Inc, United States
Title : Beyond individual choice: How social influence shapes the neural foundations of economic decision-making
Alvina Ashraf, Eastern Regional High School, United States